| Ytd | 7.35% | |
| 1y | -10.01% |
| Open | 140.00 | Prev Close | 139.43 | Low | 138.14 | High | 142.81 | Mkt Cap | 16.64B |
| Vol | 935.31K | Avg Vol | 840.88K | EPS | 3.01 | P/E | 47.24 | Forward P/E | 17.20 |
| Beta | 0.72 | Short Ratio | 4.88 | Inst. Own | 94.80% | Dividend | 1.44 | Div Yield | 1.03 |
| Ex Div Date | 08-21 | Earning | 11-19 | 50-d Avg | 143.57 | 200-d Avg | 133.25 | 1yr Est | 162.47 |
J News
https://thehill.com/policy/defense/6143284-smaller-war-plants-commission-agreement/https://legacy.sb
Truist Securities analyst Jamie Cook maintains Jacobs Solutions (NYSE:J) with a Hold and lowers t
Jacobs Solutions (NYSE:J) held its third-quarter earnings conference call on Tuesday. Below is the c
Jacobs will deploy a digital twin environment to enhance operational planning and improve facility p
Pharmaceutical sales jumped 7.7% in the quarter to $16.76 billion, but medical technology division
Johnson & Johnson stock is tumbling even after the healthcare giant raised its forecast again for fu
Maye had his best game of the season with four passing touchdowns and a rushing score in a 45-17 rom
J&J Q3 2026 earnings: profit fell 96%, mainly on a $5.5 billion legal charge tied to its talc offer.
Johnson & Johnson stock fell early Tuesday as the conflict in the Middle East weighted on medical de
Healthcare giants UnitedHealth Group and Johnson & Johnson reported Q3 results on Tuesday, with both
Johnson & Johnson beat earnings this morning. Then its stock price dropped.
Johnson & Johnson beat analyst expectations in the third quarter but left Wall Street wanting more;
SLS stock gained about 0.8% in premarket trading, while IBRX rose 0.3%. Recent ownership disclosures
Shares of Johnson & Johnson slid Tuesday after the pharma giant reported another solid but imperfect
Johnson & Johnson JNJ beat profit estimates and raised its full-year forecast on Tuesday. The stock
Johnson & Johnson stock fell early Tuesday as the conflict in the Middle East weighted on medical de
Results from two chip industry bellwethers could show whether AI-driven demand can hold up against g
U.S. stocks slipped by midday Tuesday as a chip-sector rout — sparked by a 5% plunge in South Korea’
Johnson & Johnson stock is tumbling even after the healthcare giant raised its forecast again for fu
Johnson & Johnson says it is working to improve results in its medical-device business, where surger
Jayden Daniels and Josh Conerly Jr. rise, while coaching failures and shrinking roles shape the Comm